Alfredsson, G., Wode-Helgodt, B. & Sedvall, G. (1976). A mass fragmentographic method for the determination of chlorpromazine and two of its active metabolites in human plasma and CSF. Psychopharmacologia 48, 123–131.
Bouillin, D. J., Woods, H. F., Grimes, R. P. J., Grahame-Smith, D. G., Wiles, D., Gelder, M. G. & Kolakowska, T. (1975). Increased platelet aggregation responses to 5 hydroxytryptamine in patients taking chlorpromazine. British Journal of Clinical Pharmacology 2, 29–35.
Chattaway, F. D. (1931). Acetylation in aqueous alkaline solutions. Journal of the Chemical Society ii, 2495–2496.
Cowen, M. A. & Martin, W. C. (1968). Long term chlorpromazine retention and its modification by steroids. American Journal of Psychiatry 125 (2), 139–141.
Curry, S. H. (1968). Determination of nanogram quantities of chlorpromazine and some of its metabolites in plasma using gas liquid chromatography with an electron capture detector. Analytical Chemistry 40, 1251–1255.
Curry, S. H. (1971). Chlorpromazine: concentration in plasma, excretion in urine and duration of effect. Proceedings of the Royal Society of Medicine 64, 285–289.
Curry, S. H. (1976). Plasma level studies in psychotropic drug evaluation. British Journal of Clinical Pharmacology 3, 20–28.
Laverty, R. & Sharman, D. F. (1965). The estimation of small quantities of 3, 4-dihydroxyphenylethylamine in tissues. British Journal of Pharmacology and Chemotherapy 24, 538–548.
Mackay, A. V. P., Healey, A. F. & Baker, J. (1974). The relationship of plasma chlorpromazine to its 7-hydroxy and sulphoxide metabolites in a large population of chronic schizophrenics. British Journal of Clinical Pharmacology 1, 425–430.
Sakalis, G., Curry, S. H., Mould, G. P. & Lader, M. H. (1972). Physiological and clinical effects of chlorpromazine and their relationship to plasma level. Clinical Pharmacology and Therapeutics 13, 931–946.
Usdin, E. (1971). The assay of chlorpromazine and metabolites in blood, urine and other tissues. Critical Review of Clinical and Laboratory Science 2, 347–391.
Wiles, D. H., Kolakowska, T., McNeilly, A. S., Mandelbrote, B. M. & Gelder, M. G. (1976). Clinical significance of plasma chlorpromazine levels. I. Plasma levels of the drug, some of its metabolites and prolactin during acute treatment. Psychological Medicine 6, 407–415.